What is Holoprosencephaly

Holoprosencephaly is a rare structural brain malformation occurring during early embryonic development, where the forebrain fails to properly divide into two distinct hemispheres. Because Holoprosencephaly affects the central nervous system and facial development, its clinical presentation ranges from mild to severe, often necessitating multidisciplinary medical care.

What happens to the body in Holoprosencephaly?

In Holoprosencephaly, the failure of the prosencephalon (forebrain) to separate results in varying degrees of fused brain structures. This often influences facial development, as the brain and face develop concurrently in the embryo. Affected individuals may experience developmental delays, seizures, and endocrine dysfunction due to pituitary gland involvement. At DiseaseMaps.org, 10 community members currently share their lived experiences with this complex condition, highlighting the diverse ways Holoprosencephaly impacts daily life.

What are the primary classifications of Holoprosencephaly?

Clinicians typically categorize Holoprosencephaly based on the severity of the brain separation:

• Alobar: The most severe form where the brain is not divided at all.


• Semilobar: The brain is partially divided, with some separation in the back.


• Lobar: The mildest form where the brain is mostly divided but with some fused areas.


• Middle Interhemispheric Variant (MIH): A unique subtype where the middle portion of the hemispheres fails to separate.

How common is Holoprosencephaly?

Holoprosencephaly is estimated to occur in approximately 1 in 10,000 to 20,000 live births, though it is significantly more common in early pregnancy, with many cases resulting in miscarriage. The condition does not show a strong preference for geography, though it is frequently associated with specific genetic syndromes or chromosomal abnormalities, such as Trisomy 13.

What causes this condition?

The pathophysiology of Holoprosencephaly involves complex genetic and environmental interactions during the first few weeks of gestation. Mutations in genes such as SHH, SIX3, and ZIC2 are known drivers, and maternal factors like poorly controlled diabetes may increase risk. Unlike many other neurological disorders, Holoprosencephaly is defined specifically by this early failure of cleavage, distinguishing it from later-onset neurodevelopmental issues.

Next steps

• Consult a pediatric neurologist or clinical geneticist for a comprehensive evaluation.


• Connect with the community of 10 members on DiseaseMaps.org to share resources and support.


• Seek guidance from a genetic counselor to understand recurrence risks for future pregnancies.


• Coordinate care with a multidisciplinary team including endocrinologists and neurosurgeons.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Portal for rare diseases and orphan drugs


• Online Mendelian Inheritance in Man (OMIM)


• The Holoprosencephaly Foundation